Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Gilead Seladelpar gets Conditional European Marketing Authorization for Primary Biliary Cholangitis treatment

Gilead Sciences blood cancer therapy trials put on hold by USFDA

Ruchika Sharma8 Feb 2024 12:30 PM IST

The drug is an antibody treatment that blocks a type of protein, called CD47, which helps damaged cells avoid destruction by the immune system.

Unichem Labs Roha facility gets 3 USFDA observations

Piramal Pharma gets 3 USFDA observations for US facility

Ruchika Sharma8 Feb 2024 11:18 AM IST

Mumbai: Piramal Pharma has announced that the United States Food and Drug Administration (US FDA) has concluded a Pre-Approval Inspection...

NPPA Fixes Retail Price of 65 New Drugs, Ceiling Price of 20 Formulations, Details

NPPA fixes price for various FDCs having Sitagliptin, Linagliptin

Ruchika Sharma7 Feb 2024 6:00 PM IST

New Delhi: The National Pharmaceutical Pricing Authority (NPPA) has announced that it has fixed retail prices of 39 formulations under the Drugs...

Cohance Lifesciences announces USD 10 mn investment in cGMP Bioconjugation Suite at NJ Bio

Novo Nordisk parent invests in India's Manipal hospital chain

Ruchika Sharma7 Feb 2024 3:45 PM IST

Stockholm: Novo Holdings, the controlling shareholder of Danish obesity drugmaker Novo Nordisk, said on Tuesday it was investing in Indian private...

JB Pharma net profit rises 26 percent to Rs 134 crore for Q3

Ruchika Sharma7 Feb 2024 2:30 PM IST

JB Chemicals & Pharmaceuticals on Tuesday said its net profit rose 26 per cent to Rs 134 crore for the third quarter ended December 2023. The...

USFDA approves Tonix Pharma Tonmya for fibromyalgia in adults

USFDA gives tentative nod to Biocon for cancer drug Dasatinib

Ruchika Sharma7 Feb 2024 12:43 PM IST

Bangalore: Biocon Limited has received tentative approval of its Abbreviated New Drug Application (ANDA) for Dasatinib tablets from the United...

Lupin receives USFDA observations for two Pithampur manufacturing Units

Lupin bags USFDA nod for Bromfenac Ophthalmic Solution, 0.075%

Ruchika Sharma7 Feb 2024 11:45 AM IST

Bromfenac Ophthalmic Solution, 0.075% is indicated for the treatment of postoperative inflammation and prevention of ocular pain in patients...

Merck, Daiichi Sankyo Ifinatamab deruxtecan granted Breakthrough Therapy Designation by USFDA for pretreated extensive-stage small cell lung cancer

Merck Animal Health to acquire Elanco Aqua Business for USD 1.3 billion

Ruchika Sharma6 Feb 2024 4:00 PM IST

Rahway: Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway,...

CureVac announces resolution of patent litigation with Pfizer/BioNTech

Abbott Labs must face lawsuit over PediaSure height claims

Ruchika Sharma6 Feb 2024 3:00 PM IST

"The existence of studies contradicting the label's claim reinforce the plausibility of the complaint's allegation that the label would mislead a...

CDSCO Panel Clears Abbotts Phase IV Trial for Empagliflozin + Metformin FDC, Seeks More Sites

Parents seek to revive claims they overpaid for Abbott formula before recall

Ruchika Sharma6 Feb 2024 1:30 PM IST

Parents who say they overpaid for Abbott Laboratories baby formula before one of its plants was shuttered for unsanitary conditions urged a federal...

Novartis to buy Tourmaline Bio for USD 1.4 billion

Novartis to acquire MorphoSys AG for EUR 68 per share or aggregate of EUR 2.7bn in cash

Ruchika Sharma6 Feb 2024 12:30 PM IST

Basel: Novartis has announced that it has entered into an agreement to make a voluntary public takeover offer to acquire MorphoSys AG, a...

Alembic Pharma net profit rises 48 percent to Rs 180 crore in Q3

Ruchika Sharma6 Feb 2024 11:36 AM IST

Its net sales increased 8 per cent to Rs 1,631 crore for the third quarter from Rs 1,509 crore in the year ago period, Alembic Pharma said in a...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok